analyticsVertical SaaS
Data as of Q1 2026
Summary Verdict
HNGE: 4—EGHT: 1wins
Rule of 40
82.0HNGE
10.3EGHT
check_circleHNGE leads
Revenue Growth
53.5%HNGE
2.0%EGHT
check_circleHNGE leads
Gross Margin
80%HNGE
66%EGHT
check_circleHNGE leads
FCF Margin
28.5%HNGE
8.3%EGHT
check_circleHNGE leads
Operating Margin
-90.3%HNGE
3.4%EGHT
check_circleEGHT leads
NRR
—HNGE
—EGHT
Metric
Rule of 40Efficiency score
HNGE
82.0check_circle
EGHT
10.3
Revenue GrowthYoY
HNGE
53.5%check_circle
EGHT
2.0%
Gross Margin% of revenue
HNGE
80%check_circle
EGHT
66%
FCF MarginFree cash flow
HNGE
28.5%check_circle
EGHT
8.3%
Operating MarginGAAP
HNGE
-90.3%
EGHT
3.4%check_circle
NRRNet retention
HNGE
N/A
EGHT
N/A
EV / RevenueValuation multiple
HNGE
7.7x
EGHT
0.7xcheck_circle
Market CapUSD
HNGE
$4.9Bcheck_circle
EGHT
$266.8M
ARR GrowthYoY
HNGE
N/A
EGHT
N/A
CAC PaybackMonths to recover
HNGE
N/A
EGHT
N/A
Advertisement
insights
Analysis
As of Q1 2026, Hinge Health, Inc. trades at 7.7x EV/Revenue versus 8X8 INC /DE/ at 0.7x. On the Rule of 40, Hinge Health, Inc. scores 82.0 compared to 8X8 INC /DE/'s 10.3, placing Hinge Health, Inc. ahead in operating efficiency. Gross margins stand at Hinge Health, Inc. 80% vs 8X8 INC /DE/ 66%.
Sector Context
Both companies operate in the Vertical SaaS sector. The median columns above show where each company stands relative to their peers.